Viewing StudyNCT00002266



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002266
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDSARC Patients
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization: NIH AIDS Clinical Trials Information Service

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
ammonium trichlorodioxoethylene-OO-tellurute View
Drug Therapy Combination View
Acquired Immunodeficiency Syndrome View
AIDS-Related Complex View